Erik Snapp defends pharmaceutical, medical device, automotive and consumer products clients in consumer fraud class actions and product liability/mass tort litigation. He has represented Fortune 500 clients in numerous trials and has extensive multi-district litigation experience. He also has handled regulatory and internal investigations in the United States and Europe, and has advised clients on compliance and ethics issues. Mr. Snapp has been recognized by The Legal 500 US for his product liability and mass tort defense practice in the areas of consumer products, pharmaceuticals and medical devices, and toxic tort.
Mr. Snapp has argued federal and state court appeals, and has written briefs submitted to all levels of appellate courts, including the U.S. Supreme Court. He also strongly supports the firm’s pro bono commitment; his recent pro bono work includes representing members of the Oglala Lakota Nation in a Voting Rights Act case, serving as lead trial counsel in a complex interstate child custody dispute, and representing indigent criminal defendants in trial court and appellate court proceedings.
A graduate of St. John’s University (B.S., 1990, cum laude) and the University of Minnesota Law School (J.D., 1995, cum laude), Mr. Snapp is a member of the Illinois, Florida and Minnesota state bars and federal court bars in Illinois, Indiana and Wisconsin, including the Northern District of Illinois Trial Bar.
Mr. Snapp is the Program Vice-Chair of the Defense Research Institute (DRI) Drug and Medical Device (DMD) Committee, and previously served as the Chair of the DMD Complex Medicine/Experts Specialized Litigation Group. He is a member of the International Association of Defense Counsel (IADC), which is the preeminent invitation-only global legal organization for attorneys representing corporate and insurance interests. He has also served on the Law360 Life Sciences Editorial Advisory Board.
Prior to attending law school, Mr. Snapp taught English in Kyoto, Japan.